Early ophthalmologic features of Parkinson’s disease: a review of preceding clinical and diagnostic markers

被引:0
作者
Pierpaolo Turcano
John J. Chen
Britta L. Bureau
Rodolfo Savica
机构
[1] Mayo Clinic,Department of Neurology
[2] Mayo Clinic,Department of Ophthalmology
[3] Mayo Clinic,Division of Epidemiology, Department of Health Sciences Research
来源
Journal of Neurology | 2019年 / 266卷
关键词
Parkinson’s disease; Visual hallucinations; Visual-processing abnormalities; Oculomotor dysfunctions; Stereopsis impairment;
D O I
暂无
中图分类号
学科分类号
摘要
Non-motor symptoms in Parkinson’s disease are an important cause of morbidity and may even precede the onset of the motor features of the disease. Visual abnormalities are among the most frequent non-motor symptoms observed during the early stages of the disease. Some of the visual symptoms of Parkinson’s disease can likely be explained by the presence of dopaminergic neurons within the retina, where the progressive loss of dopamine and the accumulation of α-synuclein within the retinal layers leads to visual dysfunction, while some are caused by abnormalities in cortical visual processing. Many of these visual symptoms can be overlooked or go unrecognized. We review the visual symptoms in Parkinson’s disease, including visual-processing and ocular motility abnormalities, stereopsis deficits, and visual hallucinations, focusing on the early stages of the disease. We focus on the reciprocal influence between the visual symptoms and the progression of the disease, analyzing the influence of dopaminergic therapy on the visual abnormalities. Finally, we discuss the possible role of some of these visual symptoms as possible markers or early diagnostic signs of the disease.
引用
收藏
页码:2103 / 2111
页数:8
相关论文
共 597 条
[1]  
Gelb DJ(1999)Diagnostic criteria for Parkinson disease Arch Neurol 56 33-39
[2]  
Oliver E(2013)Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion Amyotrophic Lateral Scler Frontotemporal Degener 14 132-137
[3]  
Gilman S(2006)Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study Lancet Neurol 5 572-577
[4]  
Coon EA(2013)Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study Lancet Neurol 12 443-453
[5]  
Daube JR(2009)Medical records documentation of constipation preceding Parkinson disease: a case-control study Neurology 73 1752-1758
[6]  
Dejesus-Hernandez M(2011)Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder Ann Neurol 69 811-818
[7]  
Adeli A(2000)Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study Mov Disord 15 669-677
[8]  
Savica R(2003)Staging of brain pathology related to sporadic Parkinson’s disease Neurobiol Aging 24 197-211
[9]  
Parisi JE(2017)Skin disorders in Parkinson’s disease: potential biomarkers and risk factors Clin Cosmet Investig Dermatol 10 87-92
[10]  
Dickson DW(2017)The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson’s disease Eur J Neurol 24 788-795